No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Psoriasis Partnering market is a subset of the pharmaceutical industry focused on the development of drugs to treat psoriasis. It is a highly competitive market, with a wide range of companies involved in the research and development of new treatments. Companies in the market are typically focused on the development of novel therapies, such as biologics, small molecules, and topical treatments. These treatments are designed to target the underlying causes of psoriasis, such as inflammation and immune system dysfunction.
The Psoriasis Partnering market is also characterized by a high degree of collaboration between companies, as well as with academic and research institutions. This collaboration is essential for the development of new treatments, as it allows companies to share resources and expertise.
Some of the major companies in the Psoriasis Partnering market include AbbVie, Amgen, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, and UCB. These companies are all involved in the research and development of new treatments for psoriasis, and are actively partnering with other companies and institutions to further their research. Show Less Read more
